Vascular Biogenics Ltd (VBLT) - Financial and Strategic SWOT Analysis Review

  • ID: 4278294
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • VBI Vaccines
1 of 4
Summary

Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. Its product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for cancer therapy. VBL also administers treatment for solid tumor indications, with clinical trials in rGBM, thyroid cancer and ovarian cancer. The company designs its product to address oncology indications in solid tumors, by the blood vessels required for tumor growth. It develops a proprietary platform of designated Lecinoxoids, orally-available small molecules for the treatment of chronic immune-related indications. The company also developed programs based proprietary platform technologies including an oncology program and an anti-inflammatory program. VBL is headquartered in Or Yehuda, Israel.

Vascular Biogenics Ltd Key Recent Developments

Nov 14, 2017: VBL Therapeutics Announces Third Quarter 2017 Financial Results
Aug 14, 2017: VBL Therapeutics Announces Second Quarter 2017 Financial Results
Jun 15, 2017: VBL Therapeutics Announces Appointment of Dr. Corinne Epperly as U.S. Chief Operating Officer
May 15, 2017: VBL Therapeutics Announces First Quarter 2017 Financial Results

This comprehensive SWOT profile of Vascular Biogenics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vascular Biogenics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Vascular Biogenics Ltd - Key Information
  • Vascular Biogenics Ltd - Overview
  • Vascular Biogenics Ltd - Key Employees
  • Vascular Biogenics Ltd - Key Employee Biographies
  • Vascular Biogenics Ltd - Key Operational Heads
  • Vascular Biogenics Ltd - Major Products and Services
  • Vascular Biogenics Ltd - History
  • Vascular Biogenics Ltd - Company Statement
  • Vascular Biogenics Ltd - Locations And Subsidiaries
  • Vascular Biogenics Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Vascular Biogenics Ltd - Business Description
  • Vascular Biogenics Ltd - Corporate Strategy
  • Vascular Biogenics Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Vascular Biogenics Ltd - Strengths
  • Vascular Biogenics Ltd - Weaknesses
  • Vascular Biogenics Ltd - Opportunities
  • Vascular Biogenics Ltd - Threats
  • Vascular Biogenics Ltd - Key Competitors
Section 3 - Company Financial Performance Charts
  • Vascular Biogenics Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Vascular Biogenics Ltd, Key Information
  • Vascular Biogenics Ltd, Key Ratios
  • Vascular Biogenics Ltd, Share Data
  • Vascular Biogenics Ltd, Major Products and Services
  • Vascular Biogenics Ltd, History
  • Vascular Biogenics Ltd, Key Employees
  • Vascular Biogenics Ltd, Key Employee Biographies
  • Vascular Biogenics Ltd, Key Operational Heads
  • Vascular Biogenics Ltd, Other Locations
  • Vascular Biogenics Ltd, Subsidiaries
  • Vascular Biogenics Ltd, Key Manufacturing facilities
  • Vascular Biogenics Ltd, Key Competitors
  • Vascular Biogenics Ltd, SWOT Analysis
  • Vascular Biogenics Ltd, Ratios based on current share price
  • Vascular Biogenics Ltd, Annual Ratios
  • Vascular Biogenics Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Vascular Biogenics Ltd, Performance Chart
  • Vascular Biogenics Ltd, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll